Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...
Tesla reports its first European sales uptick in over a year, a modest but meaningful turn that investors are watchin...
Crypto gaming platform 1Win unveils a native token and dual-chain Web3 ecosystem to embed token utility across gaming...
When a chief executive sells a large block of shares, investors understandably take note. This guide breaks down what...
A leading career expert warns that overreliance on AI could dull judgment and make skilled workers more vulnerable to...
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
The 2026 maximum social security check is $5,181 per month. Here’s how large a private portfolio would need to be to ...
Salesforce faces leadership questions as founder Marc Benioff approaches three decades at the helm. The company is st...
Netflix is tightening access to viewing data as it trims public reporting on audience insights, prompting a cautious ...